Equipoise is the popularly referenced brand name for the veterinary injectable steroid Boldenone undecylenate. Specifically Equipoise is a derivative of testosterone, which exhibits strong anabolic and moderately androgenic properties. The undecylenate in Equipoise ester greatly extends the activity of the drug (the undecylenate ester is only one carbon atom longer than decanoate), so that clinically injections of Equipoise would need to be repeated every three or four weeks. In veterinary medicine Equipoise is most commonly used on horses. Equipoise exhibits a pronounced effect on lean bodyweight, appetite and general disposition of the animal. Equipoise is also said to shows a marked ability for increasing red blood cell production, although there should be no confusion that this is an effect characteristic of nearly all anabolic/androgenic steroids. The favorable properties of Equipoise are greatly appreciated by athletes, Equipoise being a very popular injectable in recent years. It is considered by many to be a stronger, slightly more androgenic Deca-Durabolin . It is generally cheaper, and could replace Deca in most cycles without greatly changing the end result.
Equipoise side effects
The side effects associated with Equipoise are generally mild. The structure of Boldenone (Equipoise) does allow it to convert into estrogen, but it does not have an extremely high affinity to do so. To try and quantify this we can look toward aromatization studies, which suggest that its rate of estrogen conversion should be roughly ha that of testosterone. The tendency to develop a noticeable amount of water retention with Equipoise would thetef ore be slightly higher than that with Deca-Durabolin (with an estimated 20% conversion), but much less than ihat would be expected with a stronger agent such as Testosterone. While one does still have a chance of encqtintering an estrogen related side effect as such when using this substance, it is not a common problemwheh taken at a moderate dosage level. Gynecomastia might theoretically become a concern, but is usually only heared of with very sensitive individuals or (again) those venturing high in dosage. Should estrogenic effects become troublesome, the addition of Nolvadex and/or Proviron should of course make the-cycle more tolerable. An anti aromatase such as Cytadren or Arimidex would be stronger options, however probably not indicated with a mild drug as such.
